Direct comparison
DMEM vs RPMI 1640: Buying Guide
Compare DMEM and RPMI 1640 media on formulation, cell-type fit, and the documentation to request when procuring either for a lab program.
Written and maintained by CASRAI Editorial Board
Last updated
Ask CASRAI · free to try
Ask about DMEM vs RPMI 1640: Buying Guide
Ask your first 2 questions free below. Subscribers get 150 a day for $29 a month.
An AI assistant specialized in research administration. It cites the sources behind every answer, labels web answers and says when it can't answer.
Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.
Works on this site and inside Claude, Cursor and the AI tools you already use.
Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays free to read, with no account and no card.
How do DMEM, RPMI 1640 compare side by side?
The table below compares DMEM, RPMI 1640 across 8 procurement-relevant dimensions, from developed for through interchangeable mid-study?.
Side-by-side comparison
| Dimension | DMEM | RPMI 1640 |
|---|---|---|
| Developed for | Modification of Eagle’s MEM by Renato Dulbecco; broad adherent-cell use | Developed at Roswell Park Memorial Institute for human leukemic/lymphoid cells |
| Typical cell types | Adherent fibroblast/epithelial lines (HeLa, HEK293, CHO, and many others) | Lymphocytes, hybridomas, other hematopoietic/immune and suspension lines |
| Glucose concentration | High-glucose (~4.5 g/L) or low-glucose (~1 g/L) variants available | Single lower-glucose formulation (~2 g/L), closer to physiological blood glucose |
| Distinct extra components | Higher overall amino acid/vitamin concentration than base Eagle’s MEM | Reduced glutathione, biotin, vitamin B12, PABA not present in DMEM |
| Buffering options | Bicarbonate-buffered (CO₂ incubator) or HEPES-buffered variants, by catalog number | Bicarbonate-buffered (CO₂ incubator) or HEPES-buffered variants, by catalog number |
| L-glutamine / phenol red | Available with stabilized glutamine or without; with or without phenol red | Available with stabilized glutamine or without; with or without phenol red |
| GMP-grade availability | Available from major suppliers with USP <1043>/Ph. Eur. 5.2.12-aligned documentation | Available from major suppliers with USP <1043>/Ph. Eur. 5.2.12-aligned documentation |
| Interchangeable mid-study? | No — switching requires revalidation of growth/expression endpoints | No — switching requires revalidation of growth/expression endpoints |
Common questions
Common questions about DMEM vs RPMI 1640
Is RPMI 1640 the same as RPMI?
+
Yes, in current commercial catalogs. RPMI 1640 is the standard, current formulation name; the original 1960s formulation was RPMI 1630. Suppliers use "RPMI" and "RPMI 1640" interchangeably today.
Can I substitute DMEM for RPMI 1640 (or vice versa) mid-study?
+
Not without revalidation. The two media differ in glucose concentration, amino acid and vitamin load, and several minor components, and switching can measurably shift growth rate, morphology, and gene/protein expression. Treat a media change as a raw-material change requiring qualification, the same as any other critical reagent substitution.
Is one of these media more expensive to procure than the other?
+
Base catalog pricing for standard-grade DMEM and RPMI 1640 from major suppliers is generally comparable; cost differences in practice come from the grade tier (research vs. GMP-grade with full ancillary-material documentation), format (powder vs. liquid, package size), and glutamine/HEPES variant selected, not from the base formulation itself.
Do both require a CO₂ incubator?
+
Only the bicarbonate-buffered variants do. Both DMEM and RPMI 1640 are available in HEPES-buffered formulations designed for open-bench or CO₂-independent use — check the specific catalog number rather than assuming based on the media name.
What documentation should I request for GMP-grade DMEM or RPMI 1640?
+
For use as an ancillary material in cell, gene, or tissue-engineered product manufacturing, request a lot-specific certificate of analysis, sterility/mycoplasma/endotoxin testing results, animal-origin sourcing statements (including TSE/BSE status for any animal-derived components), change-notification commitments, and evidence of the supplier’s quality-management system — consistent with USP <1043>, Ph. Eur. 5.2.12, and the ISO 20399 ancillary-materials series.
